ABP-7

ABP-7 (Actin-Binding Peptide-7) is the actin-binding domain peptide derived from Thymosin Beta-4 (TB4), the endogenous G-actin sequestering protein that is the active component of the widely-studied research peptide TB-500. While TB-500 represents the entire Thymosin Beta-4 molecule, ABP-7 isolates the specific peptide sequence responsible for TB4's primary biochemical function: binding to globular actin (G-actin) monomers and preventing their polymerisation into filamentous actin (F-actin).

The actin cytoskeleton is one of the most important structural systems in animal cells. Actin exists in two forms that are in dynamic equilibrium: G-actin (the globular monomer) and F-actin (the filamentous polymer formed by polymerisation of G-actin). The balance between G-actin and F-actin determines cell shape, rigidity, motility, and the ability to generate contractile forces. This balance is regulated by numerous actin-binding proteins, of which Thymosin Beta-4 is one of the most abundant in many cell types.

By sequestering G-actin monomers, ABP-7 (and by extension TB4) reduces the pool of actin available for filament formation. This actin sequestration has complex downstream effects: cells with less F-actin are more motile (since actin network disassembly precedes cell front extension), cytoskeletal architecture is altered (affecting cell shape and mechanosensing), and signalling pathways that use actin dynamics as inputs (including Rho-GTPase signalling and nuclear mechanotransduction) are modified.

The wound healing relevance of actin sequestration stems from the critical importance of cell motility in wound closure. Wound healing requires keratinocytes and fibroblasts to migrate into the wound bed - a process that depends on coordinated actin polymerisation at the leading edge (forming lamellipodia and filopodia) and depolymerisation at the trailing edge. Modulating this cycle through actin sequestration can influence the speed and efficiency of cell migration and wound closure.

As a research tool, ABP-7 provides a more targeted means of studying actin biology than using TB-500 (which has additional activities including interactions with other proteins). The isolated actin-binding domain allows researchers to attribute observed effects specifically to actin sequestration rather than other TB4 activities.